LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation

Oncogene

Volumn 33, Issue 16, 2014, Pages 2098-2109

  Liao, Q ^a,b,c   Zeng, Z ^a,b,c   Guo, X ^c   Li, X ^a,b,c   Wei, F ^c   Zhang, W ^c   Chen, P ^c   Liang, F ^c   Xiang, B ^c   Ma, J ^a,b,c   Wu, M ^a,b,c   Tang, H ^c   Deng, M ^c   Zeng, X ^c   Tang, K ^c   Xiong, W ^a,b,c   Li, G ^a,b,c  

^a Central South University   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

interleukin 6; LPLUNC1; nasopharyngeal carcinoma; signal transducer and activator of transcription 3; tumor associated macrophages

Indexed keywords

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84899456801     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.161     Document Type: Article

References (55)

1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444
2. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4: 221-233
3. Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol 2012; 33(Suppl 1): 79-84
4. Balkwill FR, Mantovani A. Cancer-related inflammation: Common themes and therapeutic opportunities. Semin Cancer Biol 2012; 22: 33-40
5. Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 2007; 121: 2373-2380
6. De Visser KE, Coussens LM. The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 2006; 13: 118-137
7. Mantovani A. Cancer: Inflaming metastasis. Nature 2009; 457: 36-37
8. Yang Y, Zhou H, Li W, Zhou M, Zeng Z, Xiong W, et al. Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways. Mol Immunol 2007; 44: 984-992
9. Liao Q, Guo X, Li X, Chen P, Liang F, Tang H, et al. Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response. J Cancer Res Clin Oncol 2011; 138: 57-64
10. Shih J, Yuan A, Chen JJW, Yang P. Tumor-Associated macrophage: Its role in cancer invasion and metastasis. J Cancer Mol 2006; 2: 6
11. Cocco C, Airoldi I. Tumor-Associated macrophages: From cancer supporters to tumoricidal effectors. Immunotherapy 2012; 4: 667-668
12. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-Associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006; 25: 315-322
13. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012; 2012: 948098
14. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, et al. Tumor-Associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010; 362: 875-885
15. Takayama H, Nishimura K, Tsujimura A, Nakai Y, Nakayama M, Aozasa K, et al. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation. J Urol 2009; 181: 1894-1900
16. Solinas G, Germano G, Mantovani A, Allavena P. Tumor-Associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 2009; 86: 1065-1073
17. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-Type cytokine signalling and its regulation. Biochem J 2003; 374: 1-20
18. Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009; 28: 2940-2947
19. Tan EL, Selvaratnam G, Kananathan R, Sam CK. Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer 2006; 6: 227
20. Chow KC, Chiou SH, Ho SP, Tsai MH, Chen CL, Wang LS, et al. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma. Oncol Rep 2003; 10: 813-819
21. Bingle CD, Wilson K, Lunn H, Barnes FA, High AS, Wallace WA, et al. Human LPLUNC1 is a secreted product of goblet cells and minor glands of the respiratory and upper aerodigestive tracts. Histochem Cell Biol 2010; 133: 505-515
22. Bingle CD, Craven CJ. PLUNC: A novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet 2002; 11: 937-943
23. Bingle L, Bingle CD. Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. Biochem Soc Trans 2011; 39: 1023-1027
24. Shin OS, Uddin T, Citorik R, Wang JP, Della Pelle P, Kradin RL, et al. LPLUNC1 modulates innate immune responses to Vibrio cholerae. J Infect Dis 2011; 204: 1349-1357
25. Vargas PA, Speight PM, Bingle CD, Barrett AW, Bingle L. Expression of PLUNC family members in benign and malignant salivary gland tumours. Oral Dis 2008; 14: 613-619
26. Zhang B, Nie X, Xiao B, Xiang J, Shen S, Gong J, et al. Identification of tissuespecific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer 2003; 38: 80-90
27. Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F. Tumor cells and tumor-Associated macrophages: Secreted proteins as potential targets for therapy. Clin Dev Immunol 2011; 2011: 565187
28. Sgambato A, Cittadini A. Inflammation and cancer: A multifaceted link. Eur Rev Med Pharmacol Sci 2011; 14: 263-268
29. Rodriguez-Vita J, Lawrence T. The resolution of inflammation and cancer. Cytokine Growth Factor Rev 2011; 21: 61-65
30. Motilva V. Inflammation and cancer: New targets and novel therapeutic approach. Curr Pharm Des 2012; 18: 3829-3830
31. Fukuda K, Kobayashi A, Watabe K. The role of tumor-Associated macrophage in tumor progression. Front Biosci (Schol Ed) 2012; 4: 787-798
32. Sica A, Allavena P, Mantovani A. Cancer related inflammation: The macrophage connection. Cancer Lett 2008; 267: 204-215
33. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211-217
34. Zhang BC, Gao J, Wang J, Rao ZG, Wang BC, Gao JF. Tumor-Associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma. Med Oncol 2010; 28: 1447-1452
35. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: The role of tumor-Associated macrophages. Crit Rev Oncol Hematol 2008; 66: 1-9
36. Wang R, Zhang J, Chen S, Lu M, Luo X, Yao S, et al. Tumor-Associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression. Lung Cancer 2011; 74: 188-196
37. Bingle CD, Bingle L. Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim Biophys Acta 2000; 1493: 363-367
38. Di YP, Harper R, Zhao Y, Pahlavan N, Finkbeiner W, Wu R. Molecular cloning and characterization of spurt, a human novel gene that is retinoic acid-inducible and encodes a secretory protein specific in upper respiratory tracts. J Biol Chem 2003; 278: 1165-1173
39. Musa M, Wilson K, Sun L, Mulay A, Bingle L, Marriott HM, et al. Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1) in the nasal and oral cavities of mice. Cell Tissue Res 2012; 350: 455-464
40. Canny G, Levy O. Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites. Trends Immunol 2008; 29: 541-547
41. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002; 13: 357-368
42. Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptor in cancer: Implications for Translational Therapeutics. Cancer 2007; 110: 1911-1928
43. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89: 1681-1684
44. Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, et al. IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 2005; 4: 217-220
45. Hsu HS, Lin JH, Hsu TW, Su K, Wang CW, Yang KY, et al. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. Lung Cancer 2012; 75: 167-177
46. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer 2009; 9: 798-809
47. Kishimoto T. Interleukin-6: From basic science to medicine-40 years in immunology. Annu Rev Immunol 2005; 23: 1-21
48. Chen H, Lee JM, Zong Y, Borowitz M, Ng MH, Ambinder RF, et al. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol 2001; 75: 2929-2937
49. Hsiao JR, Jin YT, Tsai ST, Shiau AL, Wu CL, Su WC. Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. Br J Cancer 2003; 89: 344-349
50. Lin CM, Shyu KG, Wang BW, Chang H, Chen YH, Chiu JH. Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: An in vitro and in ovo approach. J Agric Food Chem 2010; 58: 7082-7087
51. Kim SR, Bae MK, Kim JY, Wee HJ, Yoo MA, Bae SK. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochem Biophys Res Commun 2009; 387: 342-347
52. Ataie-Kachoie P, Pourgholami MH, Morris DL. Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev 2012; 24: 163-173
53. Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, et al. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol 2006; 37: 593-605
54. Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res 2007; 56: 45-50
55. Zhang X, Xiao W, Wang L, Tian Z, Zhang J. Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp. PLoS One 2011; 6: E20965